CCCarina Carvalho‐Maia

Carina Carvalho‐Maia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carina Carvalho‐Maia has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain

    by Rita Carvalho, Liliana Santos, Inês Conde, Ricardo Leitão, Hugo Rs Ferreira, Célia Gomes, Ana Paula Silva, Fernando Schmitt, Carina Carvalho‐Maia, João Lobo, et al.

    Brain metastases are one of the most serious clinical problems in breast cancer (BC) progression, associated with lower survival rates and a lack of effective therapies. Thus, to dissect the early stages of the brain metastatic process, we studied the impact of brain organotropic BC cells’ secretomes on the establishment of the brain pre‐metastatic niche (PMN). We found that BC cells with specific tropism to the brain caused significant blood–brain barrier (BBB) disruption, as well as microglial activation, in both in vitro and in vivo models. Further, we searched for a brain‐organotropic metastatic signature, as a promising source for the discovery of new biomarkers involved in brain metastatic progression. Of relevance, we identified VGF (nerve growth factor inducible) as a key mediator in this process, also impacting the BBB and microglial functions both in vitro and in vivo. In a series of human breast tumors, VGF was found to be expressed in both cancer cells and the adjacent stroma. Importantly, VGF‐positive tumors showed a significantly worse prognosis and were associated with HER2 (human epidermal growth factor receptor 2) overexpression and triple‐negative molecular signatures. Further clinical validation in primary tumors from metastatic BC cases showed a significant association between VGF and the brain metastatic location, clearly and significantly impacting on the prognosis of BC patients with brain metastasis. In conclusion, our study reveals a unique secretome signature for BC with a tropism for the brain, highlighting VGF as a crucial mediator in this process. Furthermore, its specific impact as a poor prognostic predictor for BC patients with brain metastasis opens new avenues to target VGF to control the progression of brain metastatic disease. © 2024 The Pathological Society of Great Britain and Ireland.


  • Open Access

    Evidence of psychological and biological effects of structured Mindfulness‐Based Interventions for cancer patients and survivors: A meta‐review

    by Juliana Pedro, Sara Monteiro‐Reis, Carina Carvalho‐Maia, Rui Henrique, Carmen Jerónimo, Eunice R. Silva

    Objective: A large number of studies have been conducted exploring the effects of mindfulness programs on health outcomes, such as psychological and biological outcomes. However, there is substantial heterogeneity among studies and, consequently, in the systematic reviews/meta‐analyses. Since clinical practice is massively informed by evidence on review studies, our main objective was to summarize the reported evidence regarding the effects of structured mindfulness‐based programs on psychological, biological, and quality‐of‐life outcomes in cancer patients.Methods: We conducted a meta‐review, using a literature search from inception to June 2020 in several electronic databases using a combination of keywords including MBSR, MBCT, cancer, and meta‐analysis OR “systematic review” (PROSPERO registration CRD42020186511).Results: Ten studies met the eligibility criteria and were included. The main findings were beneficial small to medium effect sizes of Mindfulness‐Based Stress Reduction (MBSR)/Mindfulness‐Based Cognitive Therapy (MBCT)/Mindfulness‐Based Cancer Recovery (MBCR) on psychological health, such as anxiety, depression, stress, and quality of life. A beneficial effect was found for biological outcomes, albeit based on a reduced number of studies. Studies were moderate homogenous regarding the intervention, population, and outcomes explored. Results on long‐term follow‐up seem to indicate that the effects tend not to be maintained, namely in shorter follow‐ups (6 months).Conclusions: This meta‐review brings a broad perspective on the actual evidence regarding MBSR/MBCT/MBCR. We expect to contribute to future project design, focused on developing high‐quality studies and exploring the moderating effects that might contribute to biased results, as well as exploring who might benefit more from MBSR/MBCT/MBCT interventions.